Acrivon Therapeutics, Inc. Common Stock
ACRV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$81 | -$60 | -$31 | -$16 |
| Dep. & Amort. | $1 | $1 | $0 | $0 |
| Deferred Tax | $0 | -$4 | $0 | $0 |
| Stock-Based Comp. | $14 | $12 | $2 | $0 |
| Change in WC | $2 | $8 | -$2 | $0 |
| Other Non-Cash | -$3 | $1 | $0 | $1 |
| Operating Cash Flow | -$66 | -$43 | -$30 | -$14 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$1 | -$2 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$203 | -$57 | -$150 | $0 |
| Inv. Sales/Matur. | $154 | $109 | $11 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$52 | $51 | -$142 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $70 | -$0 | $104 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $51 | -$1 | -$3 | $112 |
| Financing Cash Flow | $121 | -$2 | $102 | $112 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4 | $7 | -$70 | $98 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $36 | $30 | $100 | $2 |
| End Cash | $40 | $36 | $30 | $100 |
| Free Cash Flow | -$68 | -$44 | -$32 | -$14 |